Funding · Company
Thrombolex, Inc.
Kingston, NJHealthcare
Thrombolex, Inc. of Kingston, NJ has disclosed $33M across 1 Form D offering filed with the SEC on Mar 12, 2026.
$33M
Total disclosed
1
Form D offering
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$33M
Form D · Mar 12, 2026 ↗
Q1 2026
· target $51M
Filing details
HeadquartersKingston, NJIndustryHealthcare (Other Health Care)SEC CIK0001703764Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →